Bellvitge Biomedical Research Institute-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Bellvitge Biomedical Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013145
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bellvitge Biomedical Research Institute (IDIBELL) is a research centre focused on cellular medicine. It conducts clinical and basic research for developing treatments and techniques to improve health care. IDIBELL carries its research work in the fields of cancer and human molecular genetics; neurosciences; infectious pathology and transplants; growth factors; hormones and diabetes; inflammatory, chronic and degenerative diseases; epigenetics and cancer biology. It manages the research of the Bellvitge University Hospital, the Institut Catala d’Oncologia (Catalan Institute of Oncology) and the University of Barcelona. The centre’s facilities are distributed among the Hospital Duran i Reynals, the Bellvitge University Hospital and the University of Barcelona in Bellvitge. It is headquartered in Barcelona, Spain.

Bellvitge Biomedical Research Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bellvitge Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bellvitge Biomedical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bellvitge Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bellvitge Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bellvitge Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bellvitge Biomedical Research Institute, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Oxford Immunotec Enters into Licensing Agreement with IDIBELL 10
Minoryx Therapeutics Enters into Licensing Agreement with Bellvittge Biomedical 11
Histocell Enters Into Licensing Agreement With IDIBELL For Acute Pulmonary Diseases Patent 12
Bellvitge Biomedical Research Institute – Key Competitors 13
Bellvitge Biomedical Research Institute – Key Employees 14
Bellvitge Biomedical Research Institute – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
Nov 21, 2017: The isoforms of the HP1 protein differentially regulate the organization and structure of heterochromatin 16
Oct 09, 2017: A new genetic marker accounts for up to 1.4% of cases of hereditary colon cancer 17
Oct 03, 2017: IDIBELL scientists identify a key regulator of the acquisition of immune tolerance to tumor cells in cancer patients 18
Jan 31, 2017: European experts highlight the potential of xenografts in personalized oncology 19
Dec 20, 2016: Researchers identify new suppressor effects of the NOX4 protein in liver cancer 20
Oct 04, 2016: IDIBELL: Researchers identify a key molecule in psoriasis development 21
Sep 13, 2016: Therapeutic inhibition of RANK pathway reduces breast cancer recurrence 22
Jul 08, 2016: IDIBELL scientists identify an epigenetic mechanism involved in the development of autoinflammatory diseases 23
Jun 17, 2016: The PI3K protein: A potential new therapeutic target in pancreatic neuroendocrine tumors 24
Product News 25
Apr 11, 2017: First photoactive drug for pain treatments 25
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Bellvitge Biomedical Research Institute, Pharmaceuticals & Healthcare, Key Facts 2
Bellvitge Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bellvitge Biomedical Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bellvitge Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bellvitge Biomedical Research Institute, Deals By Therapy Area, 2011 to YTD 2017 8
Bellvitge Biomedical Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Oxford Immunotec Enters into Licensing Agreement with IDIBELL 10
Minoryx Therapeutics Enters into Licensing Agreement with Bellvittge Biomedical 11
Histocell Enters Into Licensing Agreement With IDIBELL For Acute Pulmonary Diseases Patent 12
Bellvitge Biomedical Research Institute, Key Competitors 13
Bellvitge Biomedical Research Institute, Key Employees 14

★海外企業調査レポート[Bellvitge Biomedical Research Institute-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Spectris plc:企業の戦略・SWOT・財務分析
    Spectris plc - Strategy, SWOT and Corporate Finance Report Summary Spectris plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • SS&C Advent:企業の戦略的SWOT分析
    SS&C Advent - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Navid Zar Chimi Ind Co:企業の戦略的SWOT分析
    Navid Zar Chimi Ind Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sorrento Therapeutics, Inc.:企業のM&A・事業提携・投資動向
    Sorrento Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sorrento Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • BioMedomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops and markets immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube base …
  • AmerisourceBergen Corporation:企業の戦略・SWOT・財務情報
    AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report Summary AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • NBCUniversal Media LLC:企業の戦略・SWOT・財務情報
    NBCUniversal Media LLC - Strategy, SWOT and Corporate Finance Report Summary NBCUniversal Media LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Phillips 66 Co (PSX)-石油・ガス分野:企業M&A・提携分析
    Summary Phillips 66 Company (Phillips 66) is a diversified energy manufacturing and logistics company. It gathers, processes, transports and markets natural gas and petroleum products such as gasoline, diesel, aviation fuel and lubricants, and transports, fractionates and markets natural gas liquids …
  • BYD Co Ltd (1211):企業の財務・戦略的SWOT分析
    BYD Co Ltd (1211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Alleghany Corporation:企業の戦略・SWOT・財務情報
    Alleghany Corporation - Strategy, SWOT and Corporate Finance Report Summary Alleghany Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Prime Capital AG-エネルギー分野:企業M&A・提携分析
    Summary Prime Capital AG (Prime Capital) is a financial service provider that offers asset management and professional services. The company provides infrastructure investments including renewable energy, private debt and hedge fund strategies through its independent asset management and advisory se …
  • Microsemi Corp:企業の戦略的SWOT分析
    Microsemi Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Sterling Bank Plc:企業の戦略・SWOT・財務情報
    Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lung Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lung Therapeutics Inc (Lung Therapeutics) is a pharmaceutical company that offers orphan drug indications for lung injury and disease. The company provides service to underserved, life-threatening lung condition pursues an innovative treatment. Its pipeline candidates include LTI-01, single …
  • Arcelik A.S. (ARCLK):企業の財務・戦略的SWOT分析
    Arcelik A.S. (ARCLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • STATS ChipPAC Pte Ltd:企業の戦略的SWOT分析
    STATS ChipPAC Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Investcorp Bank BSc (INVCORP):企業の財務・戦略的SWOT分析
    Investcorp Bank BSc (INVCORP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • University of Melbourne-医療機器分野:企業M&A・提携分析
    Summary The University of Melbourne is an educational service provider that offers graduate, postgraduate, and research degrees. The university offers education in various fields which include arts, engineering, business and economics, architecture, building and planning, land and environment, medic …
  • Midmac Contracting Co. W.L.L.:企業の戦略・SWOT・財務情報
    Midmac Contracting Co. W.L.L. - Strategy, SWOT and Corporate Finance Report Summary Midmac Contracting Co. W.L.L. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Wakefern Food Corp.:企業の戦略的SWOT分析
    Wakefern Food Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆